TNKcell
TNKcell is a company specializing in the development and manufacturing of advanced immunotherapy treatments. Founded in 2001, TNKcell has focused on engineering T cells to target and eliminate cancer cells. Their core technology revolves around the concept of "TNK" cells, which are genetically modified T lymphocytes designed to enhance their anti-tumor activity. These modifications aim to improve the cells' ability to recognize cancer markers, persist in the body, and overcome the immunosuppressive tumor microenvironment.
The company's primary research and development efforts have been directed towards creating chimeric antigen receptor (CAR)
TNKcell's therapeutic pipeline targets various hematological malignancies and solid tumors. The company has collaborated with academic